The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery disease (CAD) prevalence, an ageing population, and increased access to ...

The sweeping United States (US) tariffs will be credit negative for Asia-Pacific (APAC), but lower-tariff countries such as Malaysia, India, and the Philippines may gain market share through trade ...